These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11462217)

  • 1. Does neuronal loss in Parkinson's disease involve programmed cell death?
    Andersen JK
    Bioessays; 2001 Jul; 23(7):640-6. PubMed ID: 11462217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and Parkinson's disease.
    Lev N; Melamed E; Offen D
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):245-50. PubMed ID: 12657363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide.
    Singh S; Dikshit M
    Brain Res Rev; 2007 Jun; 54(2):233-50. PubMed ID: 17408564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease.
    Arduíno DM; Esteves AR; Cardoso SM; Oliveira CR
    Neurochem Int; 2009 Sep; 55(5):341-8. PubMed ID: 19375464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal pathology in Parkinson's disease.
    Schulz JB; Falkenburger BH
    Cell Tissue Res; 2004 Oct; 318(1):135-47. PubMed ID: 15365812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic aspects of sporadic Parkinson's disease.
    Riederer P; Youdim MB; Mandel S; Gerlach M; Grünblatt E
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S88-91. PubMed ID: 18585078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategies for Parkinson's disease based on data derived from genetic research.
    Riess O; Berg D; Krüger R; Schulz JB
    J Neurol; 2003 Feb; 250 Suppl 1():I3-10. PubMed ID: 12761628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases.
    Waldmeier P; Bozyczko-Coyne D; Williams M; Vaught JL
    Biochem Pharmacol; 2006 Nov; 72(10):1197-206. PubMed ID: 16901468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic stem cell-derived neuron models of Parkinson's disease exhibit delayed neuronal death.
    Yamashita H; Nakamura T; Takahashi T; Nagano Y; Hiji M; Hirabayashi T; Amano T; Yagi T; Sakai N; Kohriyama T; Matsumoto M
    J Neurochem; 2006 Jul; 98(1):45-56. PubMed ID: 16805795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease: clinical aspects.
    Klockgether T
    Cell Tissue Res; 2004 Oct; 318(1):115-20. PubMed ID: 15365814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1.
    Lo CP; Hsu LJ; Li MY; Hsu SY; Chuang JI; Tsai MS; Lin SR; Chang NS; Chen ST
    Eur J Neurosci; 2008 Apr; 27(7):1634-46. PubMed ID: 18371080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxicity of MPTP to migrating neuroblasts: studies in acute and subacute mouse models of Parkinson's disease.
    He XJ; Yamauchi H; Uetsuka K; Nakayama H
    Neurotoxicology; 2008 May; 29(3):413-20. PubMed ID: 18387672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease.
    Zhang D; Anantharam V; Kanthasamy A; Kanthasamy AG
    J Pharmacol Exp Ther; 2007 Sep; 322(3):913-22. PubMed ID: 17565007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detrimental deletions: mitochondria, aging and Parkinson's disease.
    Biskup S; Moore DJ
    Bioessays; 2006 Oct; 28(10):963-7. PubMed ID: 16998822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proteomic approach in the study of an animal model of Parkinson's disease.
    De Iuliis A; Grigoletto J; Recchia A; Giusti P; Arslan P
    Clin Chim Acta; 2005 Jul; 357(2):202-9. PubMed ID: 15946658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular repair of the brain in Parkinson's disease--past, present and future.
    Sayles M; Jain M; Barker RA
    Transpl Immunol; 2004 Apr; 12(3-4):321-42. PubMed ID: 15157925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.